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AbstrAct
Introduction: National dialysis data are 
fundamental for treatment planning. 
Objective: To report data of the annual sur-
vey of the Brazilian Society of Nephrology 
about chronic renal failure patients on 
dialysis in January 2009. Methods: A sur-
vey based on data of dialysis units from 
the whole country. The data collection 
was performed by using a questionnaire 
filled out by the dialysis units in Brazil. 
Results: 427 (69.8%) of the dialysis units 
in the country answered the questionnaire. 
National data were estimated for the ove-
rall dialysis population. In January 2009, 
the total estimated number of patients on 
dialysis was 77,589. The estimated preva-
lence and incidence rates of chronic renal 
failure on maintenance dialysis were 405 
and 144 patients per million population, 
respectively. The estimated number of new 
patients starting dialysis program in 2009 
was 27,612. The annual gross mortality 
rate was 17.1%. For prevalent patients, 
39.9% were aged 65 years or older, 89.6% 
were on hemodialysis and 10.4% on peri-
toneal dialysis, 30,419 (39.2%) were on a 
waiting list of renal transplant, 27% were 
diabetics, 37.9% had serum phosphorus 
> 5.5 mg/dL and 42.8% hemoglobin < 11 
g/dL. A venous catheter was the vascu-
lar access for 12.4% of the hemodialysis 
patients. Conclusions: The prevalence of 
chronic renal failure on maintenance dialy-
sis is increasing in Brazil, although in 2009 
the estimate is lower than in 2008. The da-
ta call attention to indicators of the quality 
of maintenance dialysis that need to be im-
proved and highlight the importance of the 
census to guide chronic dialysis therapy. 
Keywords: dialysis, chronic kidney failure, 
census data.
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IntroductIon
The systematic collection and disclosure 
of information on the maintenance dialy-
sis treatment in Brazil is important to 
identify aspects that need to be improved 
and to guide health care planning. Since 
the beginning of the new millennium, the 
Brazilian Society of Nephrology (SBN) 
has made an effort to produce an annu-
al survey of patients with chronic kidney 
failure undergoing a dialysis program in 
Brazil. That is a fundamental activity of 
the SBN, which counts on the voluntary 
response of the dialysis units throughout 
the country. We report data regarding pa-
tients undergoing dialysis on January first, 
2009, based on the information provided 
by the dialysis units registered at the SBN. 
Methods
A survey about patients with chronic kid-
ney failure undergoing outpatient dialysis 
programs was conducted in all dialysis 
units registered at SBN. During the first 
semester of 2009, one questionnaire was 
available on the internet in the web site 
of the SBN, and all dialysis units of the 
country were requested to complete it and 
send their data ‘on-line’ or by fax to the 
SBN administrative office. The dialysis 
units that did not complete the form we-
re monthly requested to complete it until 
the end of the survey (July 2009). When 
necessary, the secretary of the SBN pho-
ned the responsible for the dialysis unit 
to obtain or confirm missing data. The 
questions about some sociodemographic, 
clinical, laboratory, and treatment aspects 
referred to patients undergoing dialysis on 
January first, 2009. Data regarding mor-
tality and entrance of new patients into 
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Table 1 general data abOut dialysis units, answers tO the questiOnnaire, and number Of patients  
 (2009 census)
dialysis programs referred to the month of January 
2009 and were estimated for the year.
Of the 626 dialysis units registered at the SBN in 
January 2009, 437 (69.8%) completed the question-
naire, and 412 really had a dialysis program (Table 
1). Those 412 units had 53,816 patients undergoing 
dialysis and their data were analyzed. Data were sent 
to the SBN not individually but in groups, according 
to the questions. National data were estimated, consi-
dering even the numbers expected from the units that 
did not respond the questionnaire. To these units that 
did not respond the questionnaire, the mean number 
of patients expected for the region was attributed. 
The population estimates of Brazil and each Brazilian 
geographic region used for calculating the prevalence 
and incidence rates were based on updated estimates 
of the Brazilian Institute of Geography and Statistics 
(IBGE) for January 2009.
results
Figure 1 shows the distribution of the units that com-
pleted the form, according to the Brazilian geogra-
phic regions. Such distribution is similar to that of all 
dialysis units registered in Brazil. Approximately 50% 
of the dialysis units are located in the Southeastern re-
gion. Table 2 shows the entities responsible for finan-
cing the maintenance dialysis programs in Brazil. In 
the 412 units providing chronic dialysis programs and 
that answered the questionnaire, medical care was fi-
nanced by the following entities: only the Brazilian 
Public Unified Health Care System (SUS), 16% of the 
dialysis units; SUS and health insurance, 75.3%; only 
the health insurance, 8.7% of the dialysis units. Of all 
patients, 86.7% were reimbursed by SUS, and 13.3% 
by private health insurance. 
The number of patients undergoing dialysis esti-
mated on January 2009 was 77,589, more than half 
being in the Southeastern region (Figure 2). In 2008, 
a deflection was observed in the ascending curve of 
the number of patients undergoing dialysis. However, 
an increasing tendency in the number of patients un-
dergoing dialysis in the last decade can be observed. 
The prevalence rate of dialysis treatment in 2009 was 
405 patients per million population (pmp), varying 
Active dialysis units registered at the SBN 626
Estimated number of units providing chronic dialysis programs 594
Units that answered the questionnaire 437 (69.8%)
Units with chronic programs and that answered the questionnaire 412 (65.8%)
Number of patients in the 412 units that answered the questionnaire 53,816
Total estimated number of patients undergoing dialysis in Brazil 77,589
Brazilian population in January 2009 (IBGE) 191,480,630
Table 2 dialysis treatment accOrding tO the financing entity (sbn census)
Brazilian Public Unified Health Care System (SUS) 91.3%
Only the SUS 16.0%
Health insurance agencies other than SUS 75.3%
Patients reimbursed by the SUS 86.7%
Patients reimbursed by other health insurance agencies 13.3%
Mean number of patients with other health insurance agencies per unit 16.4
Figure 1. Dialysis units that answered the questionnaire, 
according to the Brazilian geographic regions, 2009 
census.
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according to the geographic region from 165 patients 
pmp in the Northern region to 465 patients pmp in the 
Southeastern region (Figure 3). The number of patients 
beginning dialysis treatment in 2009 was estimated in 
27,612, corresponding to an incidence rate of 144 pa-
tients pmp. Thirty-five percent of the new patients had 
diabetes as their basic diagnosis. In 93% of the cases, 
the initial dialysis modality was hemodialysis.
The mean percentage of patients undergoing he-
modialysis with access through central venous ca-
theter (temporary or permanent) was 12.4%. In the 
sample assessed, 53,816 patients in January 2009, the 
monthly hospitalization rate was 5.3%, and 1% of 
the patients was hospitalized due to problems with 
the vascular access. Regarding the laboratory indices 
recommended to dialysis patients,1,2 Figure 6 shows 
the percentages of hemodialysis patients with labo-
ratory tests not conforming with the recommended 
indices as follows: Kt/V < 1.2 or urea reduction ratio 
< 65%, 19.7%; serum concentration of albumin < 3.5 
g/dL, 14.9%; serum phosphorus > 5.5 mg/dL, 37.9%; 
PTH > 300 pg/ml, 33.1%; and hemoglobin < 11 g/
dL, 42.8%.
Figure 7 shows the percentages of use of some 
medications in those patients: erythropoietin, 86%; 
intravenous iron, 57%; vitamin D, 48%; sevelamer, 
37%; and statins, 18%. 
The percentages of patients undergoing dialysis 
aged 18 years or under and 60 years or above were 
2.8% and 39.9%, respectively. Males corresponded 
to 57%. 
In January 2009, 89.6% (48,207/53,816) of the 
patients undergoing chronic dialysis were being tre-
ated with hemodialysis, and 10.4% with peritoneal 
dialysis, whose predominant modality was automated 
peritoneal dialysis (Figure 3).
Regarding the primary kidney disease, arterial 
hypertension (35%) and diabetes (27%) were the 
most frequent (Figure 4).
The prevalences of positive serology for hepatitis C 
and B viruses in patients undergoing chronic dialysis in 
Brazil were 6.9% and 1.3%, respectively, and have de-
creased annually. In 2008, the prevalences of positive 
serology for hepatitis C and B viruses were 7.6% and 
1.9%, respectively. The prevalence of positive serology 
for HIV in patients undergoing dialysis was 0.6%.
Figure 4. Percentage of patients (N) according to 
dialysis type, 2009 census.
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Figure 2. Total number of patients undergoing dialysis 
treatment in Brazil, 2009 census.
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Figure 3. Estimated prevalence of patients undergoing 
dialysis in Brazil according to the geographic region, 
2009 census
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Figure 5. Basic diagnosis of patients undergoing 
dialysis in 2008-2009, 2009 census.
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The estimated number of patients in the waiting 
list for transplantation in January 2009 was 30,419 
(39.2%).
The estimated number of deaths in 2009 was 
13,235, corresponding to a gross mortality rate of 
17.1% during that year. The major causes of death 
were as follows: cardiovascular (35%); infectious 
(24%); cerebrovascular (9%); neoplasia (7%); others 
(16%); and unknown (8%).
 
dIscussIon
This article, by using data of the Brazilian Dialysis 
Census referring to January 2009, provides an over-
view of the situation of dialysis units and of patients 
undergoing maintenance dialysis treatment in Brazil. 
The results are based on data from the dialysis units 
that answered the questionnaire, which represent ap-
proximately 70.0% of the dialysis units in the country. 
That represents an improvement as compared to the 
previous year, when only 48% of the dialysis units an-
swered the questionnaires.3 The percent distribution 
of the dialysis units that answered the questionnaire 
is very similar to the total distribution of dialysis units 
according to the Brazilian geographic region, allow-
ing for a reasonably safe generalization of the results. 
The estimates suggest a decrease in the number of 
patients and in the prevalence rate of dialysis treat-
ment as compared to 2008. However, those results 
should be carefully assessed before definitive conclu-
sions are reached, because, as already emphasized 
on the 2008 report,3 the estimates of that year were 
based on a smaller number of dialysis units (50%). 
Thus, the possibility of an overestimation of the total 
number of dialysis units in Brazil cannot be ruled out, 
which may have resulted in an overestimation of the 
prevalence for 2008. We consider the possibility of an 
overestimation for the year 2008 more feasible than 
an actual decrease in the number of dialysis patients 
in 2009. It is worth noting that the number of dialysis 
patients in 2009 was greater than that in 2007, and 
that a linear increase in the number of patients under-
going maintenance dialysis was observed from 2000 
to 2007 (Figure 2).
The results of the 2009 census draw attention to 
the large variation in the prevalence of dialysis treat-
ment in different geographic regions of the coun-
try. The lower prevalence in the Northeastern and 
Northern regions may be mainly due to a smaller 
availability of nephrology services and access to them 
in those regions rather than to a lower incidence of 
chronic kidney diseases requiring renal replacement 
therapy there. The percentage (90%) of patients 
undergoing maintenance hemodialysis is similar 
to that observed in previous surveys. According to 
the results, hypertensive nephropathy continues to 
be the major underlying kidney disease in patients 
undergoing maintenance dialysis programs in the 
country, although the importance of diabetes melli-
tus has increased in patients beginning dialysis treat-
ment.  Positive serology for hepatitis continues to 
decrease annually. It is worth noting the significant 
percentage of patients with anemia, despite the use 
of erythropoietin in the large majority of patients 
(although information on the regularity of its of-
fer lacks), as well as of intravenous iron. More re-
cently, a lower range of target values of hemoglobin 
has been recommended, which can attenuate our 
lack of scope of that indicator. A high percentage 
of patients with increased levels of phosphorus and 
PTH as compared to the target levels recommend-
ed has also been observed. However, that difficulty 
has also been observed in European countries, the 
United States of America, and Japan.4,5 The lack of 
adequacy observed in the Brazilian Census data for 
Figure 7. Percentage of patients using selected medi-
cations in 2008-2009, 2009 census.
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Figure 6. Percentage of hemodialysis patients with 
laboratory tests not conforming with the recommended 
indices in 2008-2009, 2009 census.
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controlling anemia and the indicators of mineral me-
tabolism disorders occurs despite the high percent-
age of patients using high-cost medications, such as 
erythropoietin, sevelamer, and vitamin D. The gross 
mortality rate showed an increase when compared 
with that of previous years, although that possible 
tendency is still to be confirmed in future studies. 
Despite the tendency towards an increase, the mor-
tality rate observed in Brazil remains lower than that 
reported to the USA population undergoing mainte-
nance dialysis.6 The influence of the age and co-mor-
bidity differences on the mortality rate of patients 
undergoing maintenance dialysis programs in Brazil 
and other countries should be assessed.
Our results stress the importance of the annual 
survey, despite the limited number of parameters as-
sessed and the restrictions associated to the valida-
tion of the data provided. Many relevant questions 
could not be assessed because of data collection was 
based on groups of patients. Further studies aim-
ing at validating the information presented are also 
necessary.
conclusIons
By showing the reality of renal replacement therapy 
through dialysis in our country, information deriving 
from the survey should help in defining interventions 
to improve the quality of the treatment, resulting in 
a better cost-benefit ratio. The initiative of the SBN 
to systematically collect and disclosure information 
is fundamental to continuously improve health care 
to patients with end-stage renal disease and to plan 
the national policy for dialysis treatment in Brazil. 
The SBN project of the national dialysis registry is 
ongoing and should provide more detailed informa-
tion about the situation of maintenance dialysis in 
our country in the short run.
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